A woman who has been diagnosed with uterine cancer is often required to undergo a surgical procedure, depending on how advanced the cancer is and how feasible it is to prevent cancer from spreading to other parts of the body.
A gynecologic surgeon may perform a hysterectomy to remove the cervix and the uterus of the patient if the tumor found is likely to spread to other parts of the body. In a “radical hysterectomy,” the surgeon may also need to remove some parts of the vagina. Vaginal parts like the ovaries and fallopian tubes may also be removed if the patient is menopausal. In some instances, a surgeon may want to find out whether the cancer spread to the patient’s lymph nodes by performing a “sentinel lymph node biopsy.” The procedures are then followed by strategic therapy sessions to fully suppress cancer cells.
Unfortunately, uterine cancer treatment is often expensive, leaving patients and their families struggling with great financial loss. However, if your cancer has spread as the result of a morcellation surgery, the legal team at Williams Hart may be able to work for you. Find out how we may help you get the compensation you deserve by calling (800) 220-9341.
The earliest symptom indicating that a woman may have uterine cancer is when a lump or tumor starts to develop in the uterus as a result of uncontrollable growth or change of cells in the uterine cavity. Women who are considering undergoing diagnostic tests should note the possible symptoms of this kind of reproductive cancer:
- Painful urination or other problems urinating
- Abnormal bleeding in the vagina that can come in the form of discharge or spotting
- Any pain felt around the pelvic region
- Pain during sexual intercourse
- Abnormal bleeding in the uterus or menorrhagia
Uterine cancer in the female’s reproductive system may also spread to other parts of the body. Women are advised to immediately see their physician if they experience any of these symptoms.
Unfortunately, some women who undergo a myomectomy or hysterectomy may experience the spread of uterine cancer as a result of using power morcellators during the procedure. If undergoing a morcellator surgery has caused the spread of your cancer, the lawyers at Williams Hart may be able to help you. Call our office at (800) 220-9341 to find out how we could help you receive the compensation you need for recovery.
Newsweek has recently reported that a group of gynecologists, oncologists, and women’s health experts have challenged the U.S. Food and Drug Administration’s warning notice on the use of power morcellators in uterine fibroid removal.
The physicians claimed that prohibiting the use of the electromechanical morcellator will just precipitate the use of more invasive and riskier alternative procedures and will pose more risks to the patient. The doctors issued an open letter to the FDA challenging the officials to reverse their decision to stop the use of the morcellator.
Power morcellators spawned lawsuits in recent years alleging that the device spreads uterine fibroids during surgical procedures which eventually become cancerous. The lawsuits involve mostly women, stating that they were diagnosed with leiomyosarcoma, a rare form of female cancer, after the use of morcellators.
If you have been negatively affected by the use of a power morcellator during routine surgery, the attorneys at Williams Hart may be able to help you pursue compensation for your undue suffering. Call us today at (800) 220-9341 to discuss your case.
Williams Hart is representing a Pennsylvania woman who is now the third person to file suit against the Olympus manufacturing company responsible for the PKS PlasmaSORD Bipolar Morcellator after the machine was found to have caused the spread of uterine cancer. The complaint, along with the two existing complaints, claims that Olympus either knew or should have known that the power morcellator could potentially cause the spread of undetected cancer cells during gynecological surgery.
The device was approved under a 501(k) by the U.S. Food and Drug Administration several decades ago, as it was “substantially equivalent” to previously approved technology and therefore allowed to bypass testing. The morcellator uses cutting jaws to remove tissue laparoscopically, and has caused damage by cutting through uterine fibroids that contained cancerous cells, allowing them to propagate throughout the abdomen and pelvis. The consequences are an increased rate of cancerous growth and a worsened prognosis.
The FDA eventually recognized the risks associated with these devices and published a safety warning regarding the potential danger of power morcellator use during hysterectomies and myomectomies. In response to numerous lawsuits, Johnson and Johnson voluntarily recalled all of their power morcellators in 2014. Other makers, however, have threatened to pursue legal action against individuals or parties who denounce their product.
On September 4, the U.S. Government Accountability Office (GAO) announced the launch of an investigation regarding the widespread use of power morcellators and their reputation of spreading cancerous tissues to the inner lining of the uterus. The investigation was granted after Congress members requested to investigate the U.S. Food and Drug Administration’s (FDA) approval of these devices.
The power morcellator is a medical device used in minimally invasive surgeries that breaks tissue masses into fragments. Last November, the FDA announced the health risks posed by the use of these devices, recommending that the devices should come with a warning about the possible spread of undetected uterine cancer.
If you believe that the use of this device has, in any way, negatively impacted your health, we have a team of power morcellator lawyers at Williams Hart who might be able to help you take legal action against the device’s manufacturer. Call us today at (800) 220-9341 to learn more.
Uterine cancer is considered among the deadliest types of cancer affecting women. In fact, the American Cancer Society predicts that this year, about 10,170 women will die from uterine cancer complications. The agency also said approximately 54,870 women will be diagnosed with the disease.
One of the most common endometrial cancer treatments is radiation therapy. Radiation therapy involves the use of radiation to kill cancer cells and can be performed using a machine outside the body (external beam radiation), or a radiation-filled device placed inside the body (brachytherapy). However, people undergoing radiation therapy for uterine cancer may experience some side-effects, such as rectal bleeding, bladder irritation, incontinence, and sexual problems.
Some studies showed that the risk of uterine cancer is higher among women who have undergone laparoscopic procedure involving a power morcellator. If this device has caused you harm, you might be eligible to seek compensation from the manufacturer involved. Speak with our team at Williams Hart by calling (800) 220-9341 today to learn more about filing a lawsuit.
Older age, obesity, early start of menstruation, and hormone therapy are among the many risk factors associated with uterine cancer. But apart from these, a recent study published in the Journal Cancer Epidemiology, Biomarkers & Prevention revealed that soft drinks may also increase your risk of developing this life-threatening disease.
In a study that looked into 23,000 post-menopausal women, individuals who consumed sugar-sweetened drinks were 72% more at risk of uterine cancer. Experts believe sugar-sweetened beverages increase the level of estrogen in the body. Because post-menopausal women are not able to shed their endometrial lining regularly, increased estrogen level may cause their lining to thicken, thereby increasing their risk of uterine cancer.
Unfortunately, these are not the only risk factors associated with endometrial cancer. Power morcellators, for instance, may cause the spread of undetected cancer in the uterus during laparoscopic procedures. To learn more about taking legal action after being harmed by this medical device, consult with our legal team at Williams Hart by calling (800) 220-9341 today.
Starting on May 15, U.S. health insurer Aetna began limiting its coverage of power morcellator use in hysterectomies over issues that the medical device might spread uterine cancer in women, CBC News reported on May 5.
The third largest health insurer in the country said it is cutting back its coverage for laparoscopic procedures involving power morcellators because their safety has still not been proven. However, the health insurer said it will provide exceptions for pre-menopausal women who want to preserve their fertility and are left with no other effective option. Exceptions will also be provided for women whose lives would be threatened through another treatment.
More and more health insurers in the U.S. are cutting their coverage on procedures involving power morcellator over the device’s risk of spreading undetected uterine cancer. If you have been harmed by this medical device in any way, a lawyer at Williams Hart might be able to represent you in a case against the manufacturer involved. Call us at (800) 220-9341 today.
A study involving more than 29,000 Swedish women suggested that too much sitting may increase the risk of endometrial and breast cancer, a report by The Huffington Post revealed on April 27.
The study categorized the participants into three groups: those who had a sedentary job and were not active outside of work, those with a sedentary job but were active in sports, and those who both had an active job and an active sports life.
During a follow-up period lasting 25 years, the study found that women in the first group were 2.4 times more likely to develop breast cancer and uterine cancer before menopause than those from the other groups.
Endometrial cancer does not affect only those with an inactive lifestyle. It may also affect those who have undergone laparoscopic uterine surgery involving a power morcellator – a device associated with the spread of undetected cancer in the uterus. To learn more about taking legal action against the maker of this medical device, contact our legal team at Williams Hart by calling (800) 220-9341 today.
An evaluation of the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database found that women with inoperable early-stage endometrial cancer have a better chance of survival if they undergo treatment that includes brachytherapy (BT) instead of external beam radiotherapy (EBRT) alone, Medscape revealed on April 27.
The study, which involved the analysis of 460 patients’ data from the SEER database, found that patients who took BT or BT with EBRT scored high in both 3-year overall survival and 3-year cause-specific survival. EBRT uses a radiation beam from outside the body to destroy cancer cells. BT, on the other hand, involves placing the source of radiation near the tumor to get rid of the cancer cells.
Women who have undergone a laparoscopic procedure involving power morcellators are at a higher risk of developing uterine cancer. To learn more about taking legal action against the manufacturer after being adversely affected by this medical device, consult with an attorney at Williams Hart by calling (800) 220-9341 today.